Literature DB >> 6703974

Ciliary and retinal changes in myotonic dystrophy.

S Hayasaka, M Kiyosawa, S Katsumata, M Honda, S Takase, K Mizuno.   

Abstract

We examined 15 patients with myotonic dystrophy by cycloscopy, ophthalmoscopy, and fluorescein angiography. In six cases, we found depigmentation in the relatively short ciliary processes, which may account for ocular hypotony in this disorder. Eight of the patients had retinal lesions, three with butterfly-shaped dystrophy, two with reticular dystrophy, and three with peripheral yellow flecks. These lesions were biomicroscopically at the level of the retinal pigment epithelium or in the deep retinal layer and did not substantially alter visual functions. Psychophysical and electrophysiologic test results were normal or only slightly affected. The butterfly-shaped and reticular dystrophies in myotonic dystrophy may be variant forms of patterned dystrophy of the retinal pigment epithelium. The peripheral yellow flecks in a stone-wall configuration noted in this disorder are particularly unique and, to our knowledge, have not been documented previously.

Entities:  

Mesh:

Year:  1984        PMID: 6703974     DOI: 10.1001/archopht.1984.01040030072039

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Foveal photopigment kinetics--abnormality: an early sign in myotonic dystrophy?

Authors:  J P ter Bruggen; G J van Meel; A D Paridaens; C C Tijssen; D van Norren
Journal:  Br J Ophthalmol       Date:  1992-10       Impact factor: 4.638

Review 2.  Ophthalmic manifestations of inherited neurodegenerative disorders.

Authors:  Hannah M Kersten; Richard H Roxburgh; Helen V Danesh-Meyer
Journal:  Nat Rev Neurol       Date:  2014-05-20       Impact factor: 42.937

3.  Ophthalmic findings in myotonic dystrophy type 2: a case series.

Authors:  Hannah M Kersten; Helen V Danesh-Meyer; Richard H Roxburgh
Journal:  J Neurol       Date:  2016-11-02       Impact factor: 4.849

4.  Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy.

Authors:  M S Zinkernagel; S J Hornby; R E MacLaren
Journal:  Eye (Lond)       Date:  2012-10-05       Impact factor: 3.775

5.  Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1.

Authors:  Hannah M Kersten; Richard H Roxburgh; Nicholas Child; Philip J Polkinghorne; Chris Frampton; Helen V Danesh-Meyer
Journal:  J Neurol       Date:  2013-10-17       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.